The leading Baltic private equity fund INVL Baltic Sea Growth Fund continues to grow its investment portfolio and has acquired MiniVet, a Vilnius-based vet clinic network.
MoreINVL Baltic Sea Growth Fund (“the Fund”), leading private equity investment fund located in the Baltic region, is pleased to announce a renewed direction in the development of its environmental, social, and governance (“ESG”) operations. This initiative will further strengthen its overall commitment to achieving sustainability along with the continued creation of real long-term value add for its work force, key stakeholders, umbrella of portfolio companies and investor base respectively.
MoreINVL Baltic Sea Growth Fund, the leading private equity investment fund in the Baltic region, signed an agreement to acquire one of the most modern medical treatment centres in Birštonas, Nemunas as well as the largest rehabilitation and post-acute care treatment centres in the Baltics, Eglės Sanatorija.
MoreThe shareholders approved the annual report of InMedica – a network of medical clinics – and allotted part of the profit to the payment of dividends. InMedica will pay its shareholders € 2 million in dividends for 2021, which will account for 36% of the company’s total profits, most of which will be used for further business development. This decision was taken on the 31st of May at the InMedica shareholders’ meeting.
MoreThe largest Lithuanian network of medical clinics InMedica has acquired a private J. Pauliukas Family Clinic in Panevėžys, which provides family medical services. This is InMedica’s first investment in family clinics in the city.
MoreThe leading private medical chains InMedica and MediCA Group have completed the largest merger in Lithuanian healthcare clinic history to date.
MoreThe Competition Council has deemed the concentration conditions to be appropriately implemented, effectively permitting the merger between private medicine networks InMedica and MediCA Group.
MoreIn pursuance of private medical networks InMedica and MediCA Group joining forces, InMedica is announcing the transfer of its business. In compliance with the concentration conditions set by the Competition Council that are obligatory for the implementation of the merger of the two networks, part of the secondary level outpatient activities in Kaunas and Šiauliai were transferred to Affidea Lietuva UAB. According to the representatives of InMedica, the transferred activities accounted for about 1% of the company’s annual turnover.
MoreVilnius/Riga/Tallinn, Nasdaq Baltic Market, February 17 2022 – Nasdaq (Nasdaq: NDAQ) announces that a second issue of InMedica bonds has been admitted to trading on the Nasdaq Baltic First North market by Nasdaq Vilnius effective February 17, 2022.
More